Dermatology for Primary Care

Effective dermatologic care is a cornerstone of primary care practice, as skin complaints are among the most common reasons patients seek medical attention. Mastering the recognition and initial management of key conditions not only improves patient outcomes but also streamlines appropriate specialist referrals. This guide focuses on building essential visual diagnosis skills and pragmatic treatment pathways for the dermatologic presentations you will encounter daily.

Core Principles of Visual Diagnosis and Dermoscopy

Accurate dermatologic diagnosis begins with a systematic visual assessment. Develop a consistent approach: first, identify the primary lesion (e.g., macule, papule, plaque, vesicle, nodule). Next, note its distribution—is it localized, generalized, symmetrical, or in a sun-exposed area? Finally, observe any associated features like scale, crust, or erythema. This disciplined observation often narrows the differential diagnosis significantly.

For suspicious pigmented lesions, dermoscopy is a non-invasive technique that uses a handheld device to magnify and illuminate the skin, allowing visualization of structures below the stratum corneum. While proficiency requires training, understanding its role is key. It enhances melanoma detection accuracy over naked-eye examination alone. In primary care, familiarity with dermoscopy can help you better identify which lesions warrant a biopsy or urgent referral, moving beyond a general "ABCDE" checklist to a more nuanced assessment.

Management of Common Inflammatory Conditions

Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit. Treatment hinges on addressing the four pathogenic factors: follicular hyperkeratinization, increased sebum, Cutibacterium acnes proliferation, and inflammation. A stepwise approach is effective. For mild comedonal acne, start with topical retinoids (e.g., adapalene). For mild to moderate inflammatory acne, add topical benzoyl peroxide, often combined with a topical antibiotic like clindamycin to reduce resistance. Moderate to severe nodular acne typically requires oral antibiotics (e.g., doxycycline) combined with topical therapy, with isotretinoin reserved for severe, scarring, or treatment-resistant cases.

Eczema, specifically atopic dermatitis, presents with pruritic, erythematous, and often lichenified plaques, typically in flexural areas. The cornerstone of management is barrier repair through consistent, frequent use of emollients. For acute flares, topical corticosteroids remain first-line anti-inflammatory therapy; choose potency based on lesion severity and body location (e.g., low potency for face, higher for thick plaques on limbs). Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are steroid-sparing agents for sensitive areas. Always address trigger avoidance and the "itch-scratch cycle."

Psoriasis classically presents with well-demarcated, erythematous plaques with silvery scale, commonly on elbows, knees, scalp, and lumbar area. Unlike eczema, it is often non-pruritic. First-line treatment involves topical agents: high-potency corticosteroids for body plaques, vitamin D analogues (calcipotriene), or combination products. For more extensive disease, phototherapy or systemic agents (methotrexate, cyclosporine, biologics) are used, necessitating dermatology referral. Distinguishing psoriasis from eczema is critical, as treatment with potent topical steroids for misdiagnosed plaque psoriasis can be appropriate, while using them for misdiagnosed tinea (a fungal infection) can worsen it.

Recognition and Treatment of Infections & Neoplasia

Superficial fungal infections (dermatophytoses) include tinea corporis (ringworm), tinea pedis (athlete's foot), and tinea cruris (jock itch). They typically present as annular, scaly, erythematous plaques with central clearing and a raised, advancing border. Diagnosis is often clinical but can be confirmed by potassium hydroxide (KOH) preparation of skin scrapings, which reveals fungal hyphae. Treatment involves topical antifungals (azole or allylamine classes) for limited disease and oral terbinafine or itraconazole for extensive, nail, or scalp involvement.

Skin cancer screening is a vital preventive service. You must be adept at recognizing basal cell carcinoma (pearly papule with telangiectasias), squamous cell carcinoma (scaly, hyperkeratotic plaque or nodule, often on sun-damaged skin), and melanoma. The ABCDE mnemonic for melanoma remains a foundational tool: Asymmetry, irregular Border, Color variation, Diameter >6mm, and Evolution. Any changing, symptomatic, or atypical pigmented lesion requires a low threshold for biopsy or referral. Dermoscopy, as mentioned, refines this evaluation.

Addressing Drug Eruptions and Wound Assessment

Drug eruptions are adverse cutaneous reactions to medications. Morbilliform (maculopapular) eruptions are most common, appearing as symmetric, confluent pink macules and papules. They typically begin 7-14 days after starting a new drug. While often self-limiting upon discontinuation of the culprit agent, you must recognize severe reactions like DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms), Stevens-Johnson Syndrome, and toxic epidermal necrolysis, which feature mucosal involvement, blistering, and systemic illness and constitute medical emergencies.

Comprehensive wound assessment in primary care involves evaluating cause, location, dimensions, tissue type (necrotic, granulation, epithelial), signs of infection, and vascular/neurological status of the limb. Proper management includes sharp debridement of non-viable tissue, appropriate dressings to maintain a moist wound environment (e.g., hydrocolloids for clean, shallow wounds; foams or alginates for exudative wounds), and addressing underlying factors like pressure, diabetes, or venous insufficiency. Uncomplicated, non-healing wounds beyond 4 weeks warrant reassessment for atypical causes or specialist referral.

Common Pitfalls

1. Treating Tinea with Steroids: Applying a topical steroid to a fungal infection (tinea) temporarily reduces inflammation, creating a less scaly, more ill-defined lesion known as tinea incognito. This masks the typical appearance and can lead to a deeper, more widespread infection. Always consider a KOH preparation for scaly, annular rashes before initiating steroid therapy.
2. Underestimating Atypical Presentations of Melanoma: Not all melanomas follow the ABCDE rules. Amelanotic melanomas lack pigment and can appear pink or red. Nodular melanomas grow rapidly and may be symmetrical. Any new, persistent, or evolving lesion, regardless of its color or perfect symmetry, requires careful evaluation and a low threshold for referral.
3. Overlooking the Scalp, Nails, and Mucosa: Many conditions manifest in these areas. Psoriasis or fungal infections can be isolated to the scalp or nails. Always examine these sites when a patient presents with a generalized rash or when the diagnosis is unclear.
4. Failing to Taper Topical Corticosteroids: Abruptly stopping a mid- to high-potency topical steroid used for inflammatory conditions like eczema or psoriasis can lead to a severe rebound flare. Educate patients on a structured taper (e.g., moving from daily to every-other-day application) and emphasize the concurrent, ongoing use of emollients.

Summary

• Systematic visual assessment—evaluating primary lesion morphology, distribution, and secondary features—is the foundation of dermatologic diagnosis in primary care.
• First-line management of common conditions follows logical algorithms: topical retinoids and benzoyl peroxide for acne; emollients and topical steroids for eczema; and topical antifungals for limited tinea infections.
• Skin cancer screening requires vigilance for the ABCDEs of melanoma and familiarity with the appearance of non-melanoma skin cancers, with dermoscopy serving as a valuable adjunctive tool.
• Recognize that drug eruptions are common, but identifying severe cutaneous adverse reactions (like blistering or mucosal involvement) is a critical emergency skill.
• Establish clear referral criteria for dermatology subspecialty evaluation, including diagnostic uncertainty, failure of first-line therapies, suspected severe drug reactions, and management of complex wounds or skin cancers.